Related Experiment Video
Updated: Aug 10, 2026
09:25
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
[Therapeutic guidelines in chronic fatigue syndrome]
J M Bertolín Guillén1, J Bedate Villar
1Centro de Salud Mental, Diputación Provincial-Servicio Valenciano de Salud.
Actas Luso-Espanolas De Neurologia, Psiquiatria Y Ciencias Afines
|May 1, 1994
Summary
Current Chronic Fatigue Syndrome (CFS) treatments are not definitive due to unknown causes and varied definitions. Antidepressants and cognitive behavioral therapy show promise, but a comprehensive, individualized approach is needed.
Area of Science:
- Medical Science
- Immunology
- Neurology
Context:
- Chronic Fatigue Syndrome (CFS) lacks definitive treatments, hindering patient management.
- Etiology of CFS is complex, linked to infections, neuromuscular issues, neuro-endocrine-immune alterations, and psychiatric disorders.
- Existing therapeutic strategies have yielded insufficient results.
Purpose:
- To review the current state of CFS treatment.
- To explore various pharmacological and non-pharmacological interventions for CFS.
- To highlight promising therapeutic avenues and the need for integrated management.
Summary:
- Numerous treatments, including immunomodulators, antivirals, muscle relaxants, and anti-inflammatories, have been tried with limited success.
- Antidepressants, particularly amfebutamone and selective serotonin-reuptake inhibitors, demonstrate potential efficacy.
- Non-pharmacological approaches like cognitive behavioral treatment and a holistic "psychiatric management" model are recommended.
Impact:
- Identifies the limitations of current CFS treatments.
- Suggests that antidepressants and integrated psychiatric management offer more promising outcomes.
- Emphasizes the need for individualized, interdisciplinary interventions for effective CFS patient care.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:24Muscle Recovery and Fatigue
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...